Malignant Histiocytic and Dendritic Cell Neoplasm

Malignant Histiocytic and Dendritic Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07778212	Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL	recruiting	N/A	30	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Aug 21, 2026	clinicaltrials
NCT07389356	Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL	not yet recruiting	N/A	70	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	Feb 5, 2026